Biocon net surges by 33% to Rs 77 crore - pharmabiz.com
pharmabiz.comThe existing verticals in branded formulations (diabetology, oncotherapeutics, nephrology and cardiology) have posted a combined strong YoY growth of 28 per
...
read more